Justin Killebrew
Senior Director, Immuno-Oncology Discovery at Good Therapeutics
About
Dr. Justin Killebrew brings over 15 years of research and drug discovery experience in the areas of oncology and immunology. He joined Good Therapeutics in 2018 and transitioned to Bonum Therapeutics following the acquisition by Roche in 2022. Before joining Good, he was Director of Discovery Biology at Silverback Therapeutics, where he oversaw in vitro and in vivo research in support of their lead ADC program.
Prior to Silverback, he held positions of increasing responsibility within the research organization at Bristol-Myers Squibb, where he advanced multiple therapeutic programs within the areas of Immuno-Oncology and Immunoscience. Dr. Killebrew received his Ph.D. in Immunology from the University of Washington.
Timeline
Senior Director, Immuno-Oncology Discovery
Current role
Director of Immuno-Oncology Discovery
The Org
helps you hire
great candidates
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.
It’s free to use - try it out today.